These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

522 related items for PubMed ID: 26692288

  • 1. Carbidopa/Levodopa ER Capsules (Rytary(®), Numient™): A Review in Parkinson's Disease.
    Greig SL, McKeage K.
    CNS Drugs; 2016 Jan; 30(1):79-90. PubMed ID: 26692288
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of Rytary®, An Extended-Release Capsule Formulation of Carbidopa-Levodopa.
    Mittur A, Gupta S, Modi NB.
    Clin Pharmacokinet; 2017 Sep; 56(9):999-1014. PubMed ID: 28236251
    [Abstract] [Full Text] [Related]

  • 3. Long-Term Treatment with Extended-Release Carbidopa-Levodopa (IPX066) in Early and Advanced Parkinson's Disease: A 9-Month Open-Label Extension Trial.
    Waters CH, Nausieda P, Dzyak L, Spiegel J, Rudzinska M, Silver DE, Tsurkalenko ES, Kell S, Hsu A, Khanna S, Gupta S.
    CNS Drugs; 2015 Apr; 29(4):341-50. PubMed ID: 25895021
    [Abstract] [Full Text] [Related]

  • 4. Effect of Concomitant Medications on the Safety and Efficacy of Extended-Release Carbidopa-Levodopa (IPX066) in Patients With Advanced Parkinson Disease: A Post Hoc Analysis.
    LeWitt PA, Verhagen Metman L, Rubens R, Khanna S, Kell S, Gupta S.
    Clin Neuropharmacol; 2018 Apr; 41(2):47-55. PubMed ID: 29432286
    [Abstract] [Full Text] [Related]

  • 5. Safety of IPX066 , an extended release carbidopa-levodopa formulation, for the treatment of Parkinson's disease.
    Kestenbaum M, Fahn S.
    Expert Opin Drug Saf; 2015 May; 14(5):761-7. PubMed ID: 25697185
    [Abstract] [Full Text] [Related]

  • 6. Conversion to carbidopa and levodopa extended-release (IPX066) followed by its extended use in patients previously taking controlled-release carbidopa-levodopa for advanced Parkinson's disease.
    Tetrud J, Nausieda P, Kreitzman D, Liang GS, Nieves A, Duker AP, Hauser RA, Farbman ES, Ellenbogen A, Hsu A, Kell S, Khanna S, Rubens R, Gupta S.
    J Neurol Sci; 2017 Feb 15; 373():116-123. PubMed ID: 28131167
    [Abstract] [Full Text] [Related]

  • 7. Single-Dose Pharmacokinetics and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson Disease: A Comparison With Immediate-Release Carbidopa-Levodopa and With Extended-Release Carbidopa-Levodopa Capsules.
    Modi NB, Mittur A, Rubens R, Khanna S, Gupta S.
    Clin Neuropharmacol; 2019 Feb 15; 42(1):4-8. PubMed ID: 30520758
    [Abstract] [Full Text] [Related]

  • 8. Comparison of IPX066 with carbidopa-levodopa plus entacapone in advanced PD patients.
    Stocchi F, Hsu A, Khanna S, Ellenbogen A, Mahler A, Liang G, Dillmann U, Rubens R, Kell S, Gupta S.
    Parkinsonism Relat Disord; 2014 Dec 15; 20(12):1335-40. PubMed ID: 25306200
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the pharmacokinetics of an oral extended-release capsule formulation of carbidopa-levodopa (IPX066) with immediate-release carbidopa-levodopa (Sinemet(®)), sustained-release carbidopa-levodopa (Sinemet(®) CR), and carbidopa-levodopa-entacapone (Stalevo(®)).
    Hsu A, Yao HM, Gupta S, Modi NB.
    J Clin Pharmacol; 2015 Sep 15; 55(9):995-1003. PubMed ID: 25855267
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease.
    Pahwa R, Lyons KE, Hauser RA, Fahn S, Jankovic J, Pourcher E, Hsu A, O'Connell M, Kell S, Gupta S, APEX-PD Investigators.
    Parkinsonism Relat Disord; 2014 Feb 15; 20(2):142-8. PubMed ID: 24055014
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial.
    Hauser RA, Hsu A, Kell S, Espay AJ, Sethi K, Stacy M, Ondo W, O'Connell M, Gupta S, IPX066 ADVANCE-PD investigators.
    Lancet Neurol; 2013 Apr 15; 12(4):346-56. PubMed ID: 23485610
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.